Preclinical progress with CHF2819, a nov
โ
Tommaso Cassano; M. Rosaria Carratรน; Addolorata Coluccia; Vincenzo Di Giovanni;
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 211 KB
## Abstract (โ)โ(3aS,8aS,1S)โ1,2,3,3a,8,8aโhexahydroโ1,3a,8โtrimethylpyrrolo[2,3โb]indolโ5โolโ2โฒโethylphenylcarbamate Nโoxide hydrochloride (CHF2819) is a novel, orally active acetylcholinesterase inhibitor (AChEI) for Alzheimer's disease (AD). CHF2819 appears as a selective inhibitor of AChE, bein